SFC/HKMA調查:股票掛鉤產品去年銷售按年增長43% 爲去年最暢銷結構性產品種類
證監會與金管局今日(4日)發表有關非交易所買賣投資產品分銷情況的年度聯合調查結果顯示,在強勁市場動力下蓬勃發展,股票掛鉤產品依然是最暢銷的結構性產品種類,其銷售達17,290億元,按年增長43%,
調查結果顯示,去年所有主要投資產品種類均錄得顯着的銷售增長。認可集體投資計劃的銷售上升96%至14,000億元,結構性產品及債務證券的銷售分別按年上升30%及29%。受訪公司表示,普遍觀察到投資者情緒較一年前高漲,積極追求符合其風險胃納及投資目標的產品。
另外,從事投資產品銷售的公司數目上升9%至414家的新高,當中多達46%的公司的銷售錄得一倍以上的按年增幅。大型公司數目上升12%至101家。此外,負責分銷投資產品的人員增加4%至超過19,000名,而完成至少一項交易的客戶則增加28%至超過120萬名,數目均創下歷史新高。
證監會中介機構部執行董事葉志衡表示,產品銷售顯着上升,突顯這些公司對本港金融市場的投入及投資者對市場的信任。金管局助理總裁(銀行操守)區毓麟表示,投資交易的強勁增長,反映投資者對香港投資市場活力的信心及興趣,並支持市場生態持續增長和發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.